enexia tirzepatide FDA confirms shortage is still over, gives compounders a grace period Tirzepatide Cost: Pharmacy Pricing and

Many insurance plans impose prior authorization, step-therapy requirements, or BMI/comorbidity restrictions, creating months-long treatment delays

This asset is highly complementary to our Phase 3 FSGS program and broadens our development footprint across the kidney disease continuum, from acute injury through to chronic disease." Dr Nina Webster, CEO & Managing Director, Dimerix Limited #Dimerix #KidneyDisease #RareDisease #Biopharma #DrugDevelopment #ClinicalTrials #Nephrology #PrecisionMedicine #HealthcareInnovation #Biotech To view or add a comment, sign in ICYMI: Early phase 1 data from Bambusa Therapeutics suggests #BBT001 delivered rapid, durable improvements in atopic dermatitis severity and itch, with sustained biomarker suppression, favorable safety, and the potential for dosing as infrequently as every 3 months

It is a convenient choice for research projects and lab studies

After your virtual visit, eligible patients may receive prescriptions the same day, depending on medical review and pharmacy processing